Cleveland Clinic is part of the largest scleroderma trial ever undertaken to evaluate the efficacy and safety of oral nintedanib treatment in systemic sclerosis associated interstitial lung disease.
Recent therapeutic advances that target the basic genetic defect in cystic fibrosis is proving to be a game changer in treating adult CF.
While the incidence of CTEPH is low, diagnosis is important by a specialized multidisciplinary program that can provide a surgical cure.
Pulmonary thromboendarterectomy provides significantly prolonged life expectancy for heart-lung transplant patient at Cleveland Clinic.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Probe-based confocal light endomicroscopy offers real-time microscopic images of lung parenchyma without the traditional biopsy risks.
Revising approaches to surfactant replacement therapy may improve on results of prior clinical trials to combat acute respiratory distress syndrome.
Bronchial thermoplasty is a cost-effective treatment for asthmatics at high risk of exacerbations, but following asthmatics beyond five years will provide longer efficacy and support its cost effectiveness.
Antibiotics are the most common cause of perioperative anaphylaxis, warranting careful attention in the evaluation and management of affected patients.
Changes to the U.S. organ allocation system may increase lung transplant rates by increasing access to organs.
Complex hereditary hemorrhagic telangiectasia patients need expert, coordinated, multidisciplinary care, which is available in Cleveland Clinic’s HHT Foundation International-designated Center of Excellence.